AUNTMINNIE.COM REPORTS THAT BCBS UPDATES COVERAGE FOR INSIGHTEC'S MRGFUS
July 16, 2015 -- MR-guided focused ultrasound (MRgFUS) developer INSIGHTEC announced that various Blue Cross/Blue Shield (BCBS) networks have updated coverage policies for its ExAblate MRgFUS procedure for bone metastases.
BCBS of Massachusetts, Mississippi, Idaho, and Arizona plan to cover the procedure, following BCBS networks in New Jersey and North Carolina and Health Care Service, the second largest BCBS commercial insurer in the U.S., InSightec said. The new approvals bring the total number of members covered for the procedure to 32 million.
INSIGHTEC is the global leader in MRgFUS. The Company, founded in 1999, develops and distributes a non-invasive therapy platform that is transforming medicine. INSIGHTEC is continuously expanding its applications ranging from functional neurosurgery to oncology and gynecology. MRgFUS is embraced by world-renowned physicians in more than 120 medical facilities who applaud both its clinical and economic value. The Company has received numerous innovation awards, among others from the Wall Street Journal and TIME magazine. INSIGHTEC is privately held by GE Healthcare, Elbit Imaging, York Capital Management, GEOC Hengtong Investment Limited Partnership and MediTech Advisors.